Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product
NCT06426121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 394
Last updated 2025-11-20
Summary
This study is a multi-center, randomized clinical validation. Subjects should be fully informed of this protocol and related risks, and can only be enrolled into this study after signing the informed consent form. Blood collection of the subjects at the same puncture point at a single site will be injected into the test vial and the control vial respectively, and the vials will be transferred to the BACTEC system for culture and the results will be observed. After the BACTEC system incubation completion, the vials will be subcultured. Strains grown on plates will be identified using appropriate methods and, if possible, at the species level.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
test Aerobic/F Culture Vials
an additional blood sample will be collected compared to clinical routine of blood culture, inoculated into the test culture vial, and compared with the blood culture results of the control vial collected from the same site and the same puncture point
- DIAGNOSTIC_TEST
-
control Aerobic/F Culture Vials
according to the clinical routine of blood culture, this blood sample should be collected and inoculated into the control vial, and its culture result will be collected
Sponsors & Collaborators
-
Becton, Dickinson and Company
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-26
- Primary Completion
- 2025-10-23
- Completion
- 2025-10-23
- FDA Device
- Yes
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia
NCT05210439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation
NCT07226557 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates
NCT04295915 ·Status: COMPLETED
-
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
NCT06069206 ·Status: COMPLETED ·Phase: NA
-
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
NCT05094154 ·Status: COMPLETED ·Phase: PHASE4
-
Ceftobiprole in Hospital Acquired Pneumonia
NCT00210964 ·Status: COMPLETED ·Phase: PHASE3
-
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
NCT04876430 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study
NCT03000049 ·Status: UNKNOWN
-
Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
NCT00645723 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
NCT00424190 ·Status: COMPLETED ·Phase: PHASE3
-
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
NCT01724671 ·Status: UNKNOWN
-
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
NCT02806141 ·Status: TERMINATED ·Phase: PHASE3
-
The Impact Of A Catheter Coating On Clinical Bacteriuria
NCT04461262 ·Status: UNKNOWN ·Phase: NA
-
A Study of Ceftobiprole in Patients With Fever and Neutropenia.
NCT00529282 ·Status: TERMINATED ·Phase: PHASE3
-
PCR Technic Evaluation in the Microbial Diagnostic of Septicemia in Hemodialysis Patients With Catheter.
NCT04026035 ·Status: COMPLETED
-
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
NCT05361135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria
NCT06652126 ·Status: RECRUITING
-
A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interventions
NCT01216761 ·Status: COMPLETED ·Phase: NA
-
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
NCT05613322 ·Status: TERMINATED
-
Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
NCT02683603 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization
NCT00288418 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Daptomycin Use in Chinese ICUs
NCT03588637 ·Status: COMPLETED
-
Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients
NCT07118384 ·Status: RECRUITING ·Phase: NA
-
Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis
NCT03681431 ·Status: COMPLETED ·Phase: PHASE2